The ability of metformin to enhance the cytotoxic profile of carboplatin in platinum resistant OVCAR3 ovarian cancer cells was evaluated alone and in the presence of the FAK inhibitor PF-5733228. Metformin significantly increased OVCAR3 sensitivity to both carboplatin and PF-573228.